On December 10th His Excellency Sheikh Abdulla Bin Mohamed Al Hamed, Chairman of the Department of Health -- Abu Dhabi, officially announced the launch of the world 's most comprehensive genome program, in which BGI Group will export its gene sequencing technology for the plan. The innovation plan aims to use large-scale genomic data to establish a pioneering medical system for predictive, preventive and personalized treatment. Under the leadership of Abu Dhabi's Department of Health, the plan ...

In October this year, the "Million Microbiome of Humans Project“(MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14) in Shenzhen. At that time, we interviewed key representatives of the program, including Lars Engstrand, professor at the Center for Microbial Translational Research at the Karolinska Institutet and Liu Ruixin, researcher at the Shanghai National Clinical Research Center for Metabolic Diseases. Recently, MGI officially opened a new R&D a...

High-throughput sequencing technology has developed rapidly in recent years, and has been widely used in non-invasive prenatal screening, tumor-targeted gene mutation detection, hereditary tumor detection, genetic and rare disease detection, pathogenic microorganisms and metagenomic detection, PGD / PGS However, there are many steps in high-throughput sequencing and the procedures are very complicated. From sample pre-processing and library construction to sequencing and report interpretat...

Fetal chromosome karyotype analysis is often used in prenatal examination of high-risk pregnancy. With the development of technology, the application of chromosomal microarray analysis (CMA) in prenatal diagnosis has gradually advanced, and it has become a detection of high-risk pregnancy medium- and micro-level chromosome structural variation front-line technology. High-depth whole genome sequencing (WGS) can provide a comprehensive view of the entire genome and is a high-throughput detec...

Recently, MGI interviewed Dr. Gong Mengchun, a member of the diagnostic science committee of the International Rare Disease Research Alliance (IRDiRC). He graduated from the Peking Union Medical College School of Clinical Medicine and has extensively participated in the registration of rare diseases, medical informatics research, health care national and international collaborative work on big data standardization. From the perspective of the clinical application of high-throughput sequen...

RIGA, Latvia, November 26, 2019 –BGI Research and MGI, subsidiaries of global genomics leader BGI Group, announced a collaboration with scientists around the world to sequence and analyze 10 million cells in an effort to build a comprehensive single-cell transcriptome map to be shared with the scientific community. The“10 Million Single-Cell Transcriptome Project (scT10M)” was launched today during the opening ceremony of MGI Latvia and the China-Europe Life Health Innovation Center ...